Received: 16 May 2021
Accepted: 4 September 2021
First Online: 2 October 2021
: English ethical approval was gained from East of England Cambridge Central Research Ethics Committee 17/EE/0360 (28.11.2017). Scottish ethical approval was gained from Scotland A research Ethics Committee 17/SS/0118 (07.12.2017). Written informed consent was obtained from all subjects. No subjects were under 16 years of age. All methods were carried out in accordance with relevant guidelines and regulations.
: Not applicable.
: DW received speaker fees from Desitin Pharma and speaker fees and unrestricted education grants from Rosemont Pharmaceuticals. All other authors have no competing/conflict of interest.